Greater Precision in Targeted Therapy and Immunotherapy through Blood-Based Biomarkers
Time: 2:10 pm
day: Day 2 Track B PM
Details:
- Enhancing clinical trials and treatment plans by integrating blood-testing alongside tissue-testing for a comprehensive and robust biomarker strategy
- Harnessing liquid biopsy to identify patients for personalized treatment, targeted therapies, and clinical trials
- Leveraging ctDNA for dynamic monitoring of treatment response, providing valuable real-time insights for personalized care
- Learnings and advancements from recent collaborations in the biopharmaceutical industry
